Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998. Initially, Cytokinetics focused on the possible pharmacological targets and areas of application of drugs based … See more Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases … See more Omecamtiv mecarbil, a cardiac muscle activator for the potential treatment of heart failure. In May 2024, omecamtiv mecarbil was granted fast track designation by the FDA for the treatment of chronic HF with reduced ejection fraction. Amgen purchased an … See more Official website See more WebApr 10, 2024 · Cytokinetics is also developing omecamtiv mecarbil , a cardiac muscle activator in patients with heart failure. In 2024, Cytokinetics is celebrating its 25-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle dysfunction and conditions of muscle weakness.
Cytokinetics LinkedIn
Web102 rows · Apr 11, 2024 · Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 33.36 -0.27 (-0.80%) At close: … WebFeb 28, 2024 · In 2024, Cytokinetics is celebrating its 25-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle … razorback trailers hot springs
Cytokinetics, Incorporated (CYTK) - Yahoo Finance
WebApr 11, 2024 · Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or monthly format back to when Cytokinetics, Incorporated stock was issued. WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … WebFeb 23, 2024 · Cytokinetics continues its over 20-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle dysfunction and conditions of muscle weakness. razorback track schedule